Altogether, these data suggest that SIRPα:CD47 signaling is particularly important for regulating immune responses in the context of cancer, infectious challenge and potentially, β-cell stress in subjects with high genetic risk for autoimmunity and specifically, T1D. Here, SIRPA is linked to cancer.